Catalyst
Slingshot members are tracking this event:
PEGPH20 Selected For Inclusion In Groundbreaking Clinical Trial Initiative Designed To Transform Outcomes For Pancreatic Cancer Patients
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
HALO |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 04, 2016
Related Projects
- Evaluating the Phase 2 data on PEGPH20 in Advanced Pancreatic Cancer HALO Executed On: Mar 09, 2017 at 01:00 PM EST
Related Keywords
Pegph20, Pancreatic Cancer, Hyaluronan